A study in the Journal of Diabetes, Obesity and Metabolism found that the use of metformin is safe for the cardiovascular and renal health of patients with chronic kidney disease and type 2 diabetes. However, the findings showed no consistent benefit of metformin on all-cause mortality, major adverse cardiovascular events or estimated glomerular filtration rate slope.
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.